From left: Hoyoung Khang, PL and Soyeon Kwon, Consultant at JNPMEDI ย (Photo courtesy of JNPMEDI)ย
The healthcare industry has long been centered around doctors, hospitals, and disease treatment. But today, digital healthcare is rapidly expanding, placing greater emphasis on patient experiences and personalized care.
By combining technologies from the Fourth Industrial Revolution, digital healthcare enables the real-time collection and analysis of personal medical data to support individualized treatment, prevention, and health management. It is particularly effective in areas requiring long-term care, such as chronic diseases, mental health, and musculoskeletal conditions. Thanks to remote monitoring, AI-powered diagnostics, and digital therapeutics (DTx), patients can now manage their diets and exercise via app-based alerts and receive personalized prescriptions and lifestyle guidance without visiting a clinic.
In the MyData era, patient agency growsโand so does the importance of protecting healthcare data
Patients are no longer passive recipients of care. With the advent of MyData, individuals now own and manage their medical data, using it to monitor their health, share information, and participate more actively in care decisions.
For digital healthcare to take root securely, data protection and trust are paramount. Sensitive clinical and personal data must be safeguarded through encryption, anonymization, and secure consent procedures. Patients must have control over their data, and medical providers need transparent, trustworthy decision-making systems.
In Finland, the Kanta platform consolidates health information nationwide, while Hong Kongโs eHRSS system enables secure data sharing between medical institutions. For Koreaโs healthcare and clinical data to be effectively used in real-world care, strong inter-agency collaboration and flexible policy frameworks will be essential.
Reliable clinical data is key to advancing digital healthcare
Digital healthcare can enable highly personalized and proactive care. However, to do so safely and effectively, it must be backed by trusted clinical data. That means building transparent data systems, aligning with on-site clinical trials, and developing policies that support flexibility and innovation.
Even the most advanced tools are meaningless unless clinical trials verify their safety and efficacy. In other words, clinical trials are the engine of digital healthcare. Conducting these trials, particularly for digital devices or software-based therapeutics, requires distinct expertise and collaboration with CROs (Contract Research Organizations) that specialize in digital health.
Reflecting this need, new forms of clinical trials involving digital health devices are emerging. Examples include AI-powered artificial pancreas systems that analyze diabetic patientsโ glucose data and automatically regulate insulin levels; smartphone apps that assist with posture correction and rehabilitation for knee pain; and wearable EEG devices that predict and alert patients, caregivers, and doctors of potential seizures based on brainwave analysis.
Validated through clinical trials, such devices improve access to care, empower patients to self-manage their health, and bridge the gap between medical systems and daily life.
Digital healthcare is not just about technologyโitโs about people. For innovation to deliver real value, it must be supported by trustworthy clinical data and strong partnerships. As we move toward a future of patient-centered healthcare, aligning systems, technology, and human needs will be essential. And for these innovations to be implemented safely and reliably, broader social frameworks like data privacy and flexible regulatory systems must also be in place.
๐ Read the original article (Korean): Click
From left: Hoyoung Khang, PL and Soyeon Kwon, Consultant at JNPMEDI ย (Photo courtesy of JNPMEDI)ย
The healthcare industry has long been centered around doctors, hospitals, and disease treatment. But today, digital healthcare is rapidly expanding, placing greater emphasis on patient experiences and personalized care.
By combining technologies from the Fourth Industrial Revolution, digital healthcare enables the real-time collection and analysis of personal medical data to support individualized treatment, prevention, and health management. It is particularly effective in areas requiring long-term care, such as chronic diseases, mental health, and musculoskeletal conditions. Thanks to remote monitoring, AI-powered diagnostics, and digital therapeutics (DTx), patients can now manage their diets and exercise via app-based alerts and receive personalized prescriptions and lifestyle guidance without visiting a clinic.
In the MyData era, patient agency growsโand so does the importance of protecting healthcare data
Patients are no longer passive recipients of care. With the advent of MyData, individuals now own and manage their medical data, using it to monitor their health, share information, and participate more actively in care decisions.
For digital healthcare to take root securely, data protection and trust are paramount. Sensitive clinical and personal data must be safeguarded through encryption, anonymization, and secure consent procedures. Patients must have control over their data, and medical providers need transparent, trustworthy decision-making systems.
In Finland, the Kanta platform consolidates health information nationwide, while Hong Kongโs eHRSS system enables secure data sharing between medical institutions. For Koreaโs healthcare and clinical data to be effectively used in real-world care, strong inter-agency collaboration and flexible policy frameworks will be essential.
Reliable clinical data is key to advancing digital healthcare
Digital healthcare can enable highly personalized and proactive care. However, to do so safely and effectively, it must be backed by trusted clinical data. That means building transparent data systems, aligning with on-site clinical trials, and developing policies that support flexibility and innovation.
Even the most advanced tools are meaningless unless clinical trials verify their safety and efficacy. In other words, clinical trials are the engine of digital healthcare. Conducting these trials, particularly for digital devices or software-based therapeutics, requires distinct expertise and collaboration with CROs (Contract Research Organizations) that specialize in digital health.
Reflecting this need, new forms of clinical trials involving digital health devices are emerging. Examples include AI-powered artificial pancreas systems that analyze diabetic patientsโ glucose data and automatically regulate insulin levels; smartphone apps that assist with posture correction and rehabilitation for knee pain; and wearable EEG devices that predict and alert patients, caregivers, and doctors of potential seizures based on brainwave analysis.
Validated through clinical trials, such devices improve access to care, empower patients to self-manage their health, and bridge the gap between medical systems and daily life.
Digital healthcare is not just about technologyโitโs about people. For innovation to deliver real value, it must be supported by trustworthy clinical data and strong partnerships. As we move toward a future of patient-centered healthcare, aligning systems, technology, and human needs will be essential. And for these innovations to be implemented safely and reliably, broader social frameworks like data privacy and flexible regulatory systems must also be in place.
๐ Read the original article (Korean): Click